Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases

V. Munoz*, F. Visentin, D. Foray, P. Gaule

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaborations taking place mainly through product development partnerships (PDPs). PDPs are self-governing, private non-profit R&D organizations. In contrast to push and pull instruments designed to address private-sector R&D underinvestment, PDPs have emerged voluntarily to address this public health challenge. In this study we examine how non-profit R&D collaboration for neglected diseases takes place through PDPs. We find that PDPs act as 'system integrators' that leverage the resources and capabilities of a network of public, philanthropic and private-sector partners.
Original languageEnglish
Pages (from-to)315-338
Number of pages24
JournalScience and Public Policy
Volume42
Issue number3
DOIs
Publication statusPublished - Jun 2015
Externally publishedYes

JEL classifications

  • o31 - Innovation and Invention: Processes and Incentives
  • o30 - "Technological Change; Research and Development; Intellectual Property Rights: General"

Keywords

  • R&D collaboration
  • non-profit
  • innovation
  • neglected diseases
  • RESEARCH-AND-DEVELOPMENT
  • DRUG DEVELOPMENT
  • PHARMACEUTICAL INNOVATION
  • DISCOVERY
  • MARKET
  • ECONOMICS
  • ADVANCE
  • POLICY
  • SCALE
  • SCOPE

Cite this